Insider Trading & Ownership of Ansbert Gadicke

Location: Boston, MA
Summary: The estimated net worth of Ansbert Gadicke is at least $301M dollars as of December 4, 2025. Ansbert Gadicke is the 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $146M. Ansbert Gadicke is the Director of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $103M. Ansbert Gadicke is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $27.8M. Ansbert Gadicke is the Director, 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.2M. Ansbert Gadicke is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $9.42M. Ansbert Gadicke is the Former 10% Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $4.64M.
Signature: /s/ Ansbert Gadicke, Manager of MPM Oncology Innovations Fund GP LLC, the GP of MPM Oncology Innovations Fund, L.P.
All Insider Reports: All Insider Reports

Notify me when Ansbert Gadicke files a new Insider Trading report.

Ownership of Ansbert Gadicke

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
HARP	Harpoon Therapeutics, Inc.	10%+ Owner	$146M			May 28, 2021
CGEM	Cullinan Therapeutics, Inc.	Director	$103M			Jun 22, 2022
ITOS	iTeos Therapeutics, Inc.	Former 10% Owner	$27.8M	-$8.32M	-23%	May 13, 2025
KLRS	Kalaris Therapeutics, Inc.	Director, 10%+ Owner	$11.2M			Jul 28, 2022
RPTX	Repare Therapeutics Inc.	10%+ Owner	$9.42M			Jul 9, 2021
HOWL	Werewolf Therapeutics, Inc.	Former 10% Owner	$4.64M	-$2.23M	-32.4%	Dec 2, 2025
TCRR	TCR2 THERAPEUTICS INC.	Director, 10%+ Owner				Jun 1, 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.